Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Moleculin Biotech, Inc. (MBRX) had Return on Assets of 26.73% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$5.81M |
|
-- |
|
-- |
|
$7.53M |
|
$-7.53M |
|
$13.45M |
|
$5.92M |
|
$5.92M |
|
$5.92M |
|
$5.92M |
|
$5.92M |
|
$5.92M |
|
$-7.53M |
|
$-7.53M |
|
1.18M |
|
1.18M |
|
$18.08 |
|
$18.08 |
|
| Balance Sheet Financials | |
$9.69M |
|
$0.08M |
|
$12.44M |
|
$22.13M |
|
$6.85M |
|
-- |
|
$0.27M |
|
$7.12M |
|
$15.01M |
|
$3.86M |
|
$15.01M |
|
3.20M |
|
| Cash Flow Statement Financials | |
$-22.73M |
|
-- |
|
$27.28M |
|
$4.28M |
|
$8.88M |
|
$4.60M |
|
$1.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
39.42% |
|
153.32% |
|
|
Return on Assets |
26.73% |
39.42% |
|
$4.69 |
|
$-19.19 |
|
$-19.19 |
|